Clin2
NCT06888128Likely a fitRecruiting

Psilocybin for PTSD in veterans

PTSD

Treatments studied

Part of Injuries & trauma, Mental health clinical trials.

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
15 people
Ages
21 years to 64 years
Study type
Interventional

Who can take part

  • You are a U.S. military veteran.
  • You have a current diagnosis of PTSD and symptoms are moderate to severe.
  • You have not used hallucinogens (like psilocybin or LSD) in the past 3 months and don't use them regularly.
  • You are not pregnant, nursing, or planning to become pregnant, and you use effective birth control if sexually active.
  • You do not have serious heart problems, uncontrolled high blood pressure, or history of seizures.
  • You don't have a history of bipolar disorder, schizophrenia, or a recent moderate or severe alcohol or drug use disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07332143Recruiting· Phase 2
Psilocybin-assisted therapy for PTSD in military members

This study tests whether a drug called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat PTSD in military personnel and veterans. You'll receive the drug during a supervised session, along with talk therapy, to see if it reduces PTSD symptoms.

Atlanta, Georgia
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06902974Recruiting· Phase 2
Psilocybin therapy for PTSD from sexual assault

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Rockville, Maryland
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in U.S. service members

This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.

NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut
NCT06989957Recruiting· Phase 1
Psilocybin and MDMA therapy for PTSD in veterans

This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.

Baltimore, Maryland

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.